🔴 Pyxis Oncology is trading 5% down today with biotech-sector weakness a possible backdrop

Pyxis Oncology is trading at $2.12, down 5.13%, with biotech-sector pressure a possible backdrop.

• XBI fell 2.50% during the session, offering a possible sector backdrop.
• No company-specific catalyst was identified for the October 6 move. Latest reported news was the October 2 announcement that its public offering closed October 1, raising about $110 million upfront.
• Major U.S. indexes are higher, so broad-market weakness does not explain the decline.